Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease

计划入组 168 人 · 首次发布于 2021 年 11 月 10 日

A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate

计划入组 582 人 · 首次发布于 2015 年 8 月 19 日

clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases

计划入组 500 人 · 首次发布于 2024 年 4 月 30 日

anti-sclerostin antibody (bone disease)

Bone-1064

Sepia esculenta bone

Si-Bone

United States

Bone Biologics

Bone Therapeutics

Belgium

Study Reveals Critical Care Gaps and Economic Burden for Metastatic Bone Disease Patients

BoneCoT: A Whole-Body Skeleton Foundation Model Validated for Bone Metastasis Detection Across Multiple Centres

Zetagen Therapeutics Completes Enrollment in Phase 2a Trial for Novel Metastatic Breast Cancer Bone Lesion Treatment